|
|
| MRD / Regn No. |
: 20180000997 |
Date |
: 17/07/2026 |
| Patient Name |
: Jayalakshmi Karunakaran |
Age & Gender |
: 73 Yrs. / Female |
| Contact No. |
: 9840207264 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
CAD (01/Jan/2006) | TYPE 2 DM (01/Jan/2010) | A3G3A DKD (07/Dec/2021) | HYPERTENSION (15/Mar/2010) | LOSS OF PROTECTIVE SENSATION (26/Jul/2023) | A2G2 DKD (26/Jul/2023) | |
|
Subjective |
: |
LOST TO FOLLOW UP |
|
Objective |
: |
NAD |
|
Analysis |
: |
A3G3 DKD,MILD TSH ELEVATION,T2DM IMPROVED CONTROL,HYPERTENSION,LOSS OF PROTECTIVE SENSATION,A3G4 DKD |
|
Plan |
: |
CHANGE MEDICATIONS,GET NEPHROLOGY OPINON DR SARITA DASARI,SEE ME IN 1 WEEK |
|
| Salient Investigations |
: |
FUNDUS GLAUCOMA: NDR | FUNDUS MACULAR DEGENERATION: NAD | FUNDUS PHOTOGRAPH: NAD | OCULAR PRESSURE LEFT: 0.4 mmHg | OCULAR PRESSURE R: 0.4 mm HG | CREATININE: 2.2 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 23.47 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 159 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.1 % | POST PRANDIAL GLUCOSE (2HPP): 292 mg/dL | ALBUMIN (SERUM): 4 g/dL | ALKALINE PHOSPHOTASE: 68 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 17 U/L | SGPT (ALT): 14 IU/L | TOTAL BILIRUBIN: 0.2 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 37 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 81 mg/dL | TGL TRIGLYCERIDE: 163 mg/dL | TOTAL CHOLESTEROL: 151 mg/dl | UREA: 83.6 mg/dL | BUN BLOOD UREA NITROGEN: 39 mg/dL | MICROALBUMIN CREATININE RATIO: 286 mcg/mg | NT PROBNP : 887 pg/mL | HEMOGLOBIN: 8.8 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 90.3 fL | PLATELETS: 343 thou cells/ ul | FIB4: 0.97 | WBC WHITE BLOOD CELLS: 684 K/uL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ROSUVASTATIN 10 MG
CRESTOR 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY | |
|
2 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
0-14-0 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
3 |
INJECTION SEMAGLUTIDE
SUNDAE 0.25 MG
Medicine For DIABETES OBESITY |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING AND VISUAL DISTURBANCES | |
|
4 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
5 |
TABLET FINERONONE 10 MG
LYVELSA
Medicine For KIDNEY DISEASE |
PO |
1-0-0 |
AFTER FOOD
|
|
| MAY CAUSE INCREASE IN SERUM POTASSIUM | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 16/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
|
